Company profile · free preview

Humana

HUM · Updated 10/24/2026

Revenue

$129.7B

Fiscal 2025

Net income

$1.2B

Fiscal 2025

Free cash flow

$375.0M

Fiscal 2025

Net cash / (debt)

—

Fiscal 2025

Five-year financials

Fiscal year20252024202320222021
Revenue$129.7B$117.8B$106.4B$92.9B$83.1B
Net income$1.2B$1.2B$2.5B$2.8B$2.9B
Diluted EPS—————
Operating cash flow$921.0M$3.0B$4.0B$4.6B$2.3B
Free cash flow$375.0M$2.4B$3.0B$3.5B$946.0M
Cash$4.2B$2.2B$4.7B$5.1B$3.4B
Total debt—————

Where the cash went

Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.

Reinvested in capex

31.0%

of operating cash flow

Returned to owners

—

of free cash flow (buybacks + dividends)

Diluted share count

—

change 2021–2025

Capital expenditure $4.6BBar width = share of $14.7B operating cash flow
Operating cash flow$14.7B
Capital expenditure($4.6B)
Free cash flow$10.2B
Share buybacks—
Dividends paid—
Acquisitions (net)—
Net debt issued / (repaid)—
Stock-based compensation (non-cash)—

"—" means a year didn't report that line, so no total is shown rather than an estimate.

SEC filings

  • 10-K · period 2025-12-312026-02-19EDGAR

Ask anything about Humana's filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

More companies